General Pathology — MCQs
On this page
A 31-year-old man presents with infertility and aspermia. He reports chronic diarrhea with elevated quantitative stool fat, and has a history of recurrent, severe respiratory tract infections since early childhood. As a neonate, he experienced bowel obstruction due to meconium ileus. Which gene is most likely to harbor a mutation causing these symptoms?
Which factor is present in the final common terminal complement pathway?
Increased capillary permeability is caused by all of the following except?
Which of the following is false regarding Noonan syndrome?
In which of the following types of pathologic calcification is normal calcium metabolism observed?
Which of the following is referred to as the "gatekeeper of colonic neoplasia"?
What is the most common type of cell death resulting from sudden occlusion of blood supply?
Which of the following findings is characteristic of Marfan's syndrome?
Which CD marker represents the leucocyte common antigen?
Who discovered the process of phagocytosis?
General Pathology Indian Medical PG Practice Questions and MCQs
Question 731: A 31-year-old man presents with infertility and aspermia. He reports chronic diarrhea with elevated quantitative stool fat, and has a history of recurrent, severe respiratory tract infections since early childhood. As a neonate, he experienced bowel obstruction due to meconium ileus. Which gene is most likely to harbor a mutation causing these symptoms?
- A. CFTR (Correct Answer)
- B. FGFR
- C. G6PD
- D. HFE
Explanation: This patient presents with the classic triad of **Cystic Fibrosis (CF)**: chronic sinopulmonary infections, pancreatic insufficiency (steatorrhea/malabsorption), and infertility [1], [4]. ### **Explanation of the Correct Option** **A. CFTR:** Cystic Fibrosis is caused by a mutation in the *Cystic Fibrosis Transmembrane Conductance Regulator* (CFTR) gene on **chromosome 7**. [3] * **Respiratory:** Defective chloride transport leads to thick, dehydrated mucus, causing recurrent infections (notably *Pseudomonas* and *S. aureus*). [3] * **Gastrointestinal:** Thick secretions block pancreatic ducts, leading to exocrine insufficiency and fat malabsorption (steatorrhea). **Meconium ileus** is a pathognomonic neonatal presentation. [1] * **Infertility:** In males, CF typically causes **Congenital Bilateral Absence of the Vas Deferens (CBAVD)**, leading to obstructive azoospermia/aspermia. [2], [4] ### **Explanation of Incorrect Options** * **B. FGFR:** Mutations in *Fibroblast Growth Factor Receptor* (specifically FGFR3) are associated with **Achondroplasia**, characterized by dwarfism, not multisystemic mucosal disease. * **C. G6PD:** *Glucose-6-Phosphate Dehydrogenase* deficiency leads to episodic **hemolytic anemia** triggered by oxidative stress (e.g., fava beans, infections, or drugs). * **D. HFE:** Mutations in the *HFE* gene cause **Hereditary Hemochromatosis**, leading to iron overload ("Bronze Diabetes," cirrhosis, and cardiomyopathy). ### **High-Yield Clinical Pearls for NEET-PG** * **Most Common Mutation:** **ΔF508** (deletion of phenylalanine at position 508), leading to protein misfolding and degradation in the ER. [1] * **Diagnosis:** Sweat Chloride Test (>60 mEq/L) is the gold standard. [4] * **Infertility Note:** While 95% of males are infertile due to CBAVD, females are often subfertile due to thick cervical mucus. [4] * **Nasal Polyps:** Recurrent nasal polyps in a child should always prompt a workup for Cystic Fibrosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, p. 476. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 476-477. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Lumen Of Sweat Duct, pp. 475-476. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 478-479.
Question 732: Which factor is present in the final common terminal complement pathway?
- A. C3
- B. C4
- C. C5 (Correct Answer)
- D. Factor B
Explanation: ### Explanation The complement system consists of three activation pathways—**Classical, Lectin, and Alternative**—all of which converge at the level of C3 and lead to the formation of the **Terminal Pathway (Membrane Attack Complex - MAC).** [1] **Why C5 is Correct:** The terminal pathway begins with the cleavage of **C5** by C5 convertase. [1] This generates C5a (a potent anaphylatoxin) and **C5b**. C5b then serves as the anchor for the assembly of the remaining components: **C6, C7, C8, and C9**. Together, these form the **C5b-9 complex (MAC)**, which creates pores in the target cell membrane, leading to osmotic lysis. [1] Therefore, C5 is the first component of the final common terminal sequence. **Analysis of Incorrect Options:** * **A. C3:** This is the most abundant complement protein and the point where all three pathways converge. [1] However, it is considered part of the **early steps** or the "amplification loop" rather than the terminal MAC assembly. * **B. C4:** This is unique to the **Classical and Lectin pathways**. [1] It is not involved in the Alternative pathway or the final terminal sequence. * **D. Factor B:** This is a specific component of the **Alternative pathway** (forming the C3bBb convertase). It is not part of the common terminal pathway. **High-Yield Clinical Pearls for NEET-PG:** * **MAC Components:** C5b, C6, C7, C8, C9. * **Deficiency of C5-C9:** Increases susceptibility to recurrent **Neisseria** infections (meningitis and gonorrhea). * **Paroxysmal Nocturnal Hemoglobinuria (PNH):** Caused by a deficiency of DAF (CD55) and MIRL (CD59), which normally protect host cells from MAC-mediated lysis. * **Eculizumab:** A monoclonal antibody against **C5** used to treat PNH and atypical HUS. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 99-100.
Question 733: Increased capillary permeability is caused by all of the following except?
- A. Anaphylatoxin
- B. 5-hydroxytryptamine
- C. Renin (Correct Answer)
- D. Histamine
Explanation: **Explanation:** The correct answer is **Renin**. Increased capillary permeability is a hallmark of acute inflammation, leading to the formation of exudate. This process is primarily mediated by chemical substances that cause endothelial cell contraction or injury [1], [2]. **Why Renin is the correct answer:** Renin is an enzyme secreted by the juxtaglomerular cells of the kidney in response to low blood pressure or low sodium. Its primary role is to convert Angiotensinogen to Angiotensin I as part of the **Renin-Angiotensin-Aldosterone System (RAAS)**. While it plays a critical role in systemic blood pressure regulation and fluid balance, it has **no direct effect** on capillary permeability or the inflammatory response. **Why the other options are incorrect:** * **Histamine:** The most important mediator of the immediate transient response [2]. It causes vasodilation and increased vascular permeability by inducing endothelial cell contraction, creating "gaps" [1], [2]. * **5-hydroxytryptamine (Serotonin):** Found in platelet granules; it acts similarly to histamine, causing vasodilation and increased permeability during the early phases of inflammation [1]. * **Anaphylatoxins (C3a, C5a):** These fragments of the complement system trigger mast cell degranulation, leading to the release of histamine, which subsequently increases capillary permeability [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** The most common mechanism of increased permeability in acute inflammation is **endothelial cell contraction** (mediated by histamine, bradykinin, and leukotrienes) [1], [2]. * **Site:** Increased permeability occurs primarily in the **post-capillary venules** [2]. * **Starling’s Law:** Remember that edema in inflammation (exudate) is due to increased permeability, whereas edema in heart failure (transudate) is due to increased hydrostatic pressure [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 100-101. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 187-188. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 84-85.
Question 734: Which of the following is false regarding Noonan syndrome?
- A. It is autosomal recessive. (Correct Answer)
- B. It involves mutations in chromosome 12.
- C. Both males and females are affected.
- D. Low levels of clotting factors XI and XII are present.
Explanation: ### Explanation **1. Why Option A is the correct answer (False statement):** Noonan syndrome is primarily an **autosomal dominant** disorder [3]. It is often referred to as the "Male Turner Syndrome" (though it affects both sexes) and is caused by mutations in genes belonging to the RAS-MAPK pathway (RASopathies). The most common mutation involves the **PTPN11 gene**. **2. Analysis of Incorrect Options (True statements):** * **Option B:** The PTPN11 gene, which accounts for approximately 50% of cases, is located on the long arm of **chromosome 12 (12q24.1)**. * **Option C:** Unlike Turner syndrome (45,XO), which only affects females, Noonan syndrome occurs in **both males and females** with a normal karyotype (46,XY or 46,XX) [1]. * **Option D:** Hematological abnormalities are common in Noonan syndrome. Up to 30% of patients have coagulation defects, most notably **deficiencies in clotting factors XI, XII, and VIII**, as well as platelet dysfunction. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cardiac Lesion:** The most common cardiac defect is **Pulmonary Stenosis** (dysplastic valve), followed by Hypertrophic Cardiomyopathy (HCM). *Contrast this with Turner syndrome, where Coarctation of the Aorta and Bicuspid Aortic Valve are common.* [2] * **Clinical Triad:** Short stature, distinctive facial features (hypertelorism, low-set ears, ptosis), and congenital heart disease. * **Webbed Neck:** Similar to Turner syndrome, cystic hygroma or redundant skin on the back of the neck is common [1]. * **Cryptorchidism:** Frequently seen in affected males. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 175-177. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 540-541. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58.
Question 735: In which of the following types of pathologic calcification is normal calcium metabolism observed?
- A. Metastatic calcification
- B. Dystrophic calcification (Correct Answer)
- C. Ionotropic calcification
- D. Radiation calcification
Explanation: **Explanation:** Pathologic calcification is the abnormal tissue deposition of calcium salts. The correct answer is **Dystrophic calcification** because it occurs in the presence of **normal serum calcium levels** and normal calcium metabolism. **1. Why Dystrophic Calcification is Correct:** In this process, calcium salts are deposited in **dead, dying, or degenerated tissues** (e.g., areas of necrosis, aging heart valves, or atherosclerotic plaques). Since the tissue is damaged, it acts as a nidus for calcium crystallization despite systemic calcium homeostasis being perfectly normal. **2. Why the Other Options are Incorrect:** * **Metastatic Calcification:** This occurs in **normal tissues** but is secondary to **deranged calcium metabolism** (hypercalcemia) [1]. Common causes include hyperparathyroidism, vitamin D intoxication, or bone resorption due to malignancies [1], [3]. * **Ionotropic/Radiation Calcification:** These are not standard classifications of pathologic calcification. While radiation can cause tissue damage leading to dystrophic calcification, it is not a distinct category of calcium metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** On H&E stain, calcification appears as fine, white granules or clumps, appearing **basophilic** (blue-purple). * **Psammoma Bodies:** These are laminated, concentric calcifications seen in Dystrophic calcification [1]. Classic examples: **P**apillary thyroid carcinoma, **S**erous cystadenocarcinoma of ovary, **M**eningioma, and **M**esothelioma (**PSMM**). * **Metastatic Sites:** Metastatic calcification preferentially affects tissues that lose acid (high pH), such as the **gastric mucosa, kidneys, and lungs** [1], [2]. * **Initiation:** Dystrophic calcification begins in the **mitochondria** of dead cells. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 127-128.
Question 736: Which of the following is referred to as the "gatekeeper of colonic neoplasia"?
- A. APC (Correct Answer)
- B. SMAD2
- C. PTEN
- D. STK11
Explanation: The **APC (Adenomatous Polyposis Coli)** gene is a tumor suppressor gene located on chromosome **5q21**. It is known as the **"gatekeeper of colonic neoplasia"** because its mutation is the earliest identifiable event in the chromosomal instability pathway of colorectal cancer [2]. **Why APC is the correct answer:** The APC protein normally forms a complex that degrades **β-catenin** [1]. When APC is mutated or lost, β-catenin accumulates and translocates to the nucleus, where it activates the transcription of genes like *MYC* and *Cyclin D1*, promoting uncontrolled cellular proliferation [1], [2]. In the "Vogelstein model" of the adenoma-carcinoma sequence, both copies of the APC gene must be lost for an adenoma to develop. **Why the other options are incorrect:** * **SMAD2/SMAD4:** These are downstream effectors of the TGF-β signaling pathway. Mutations usually occur later in the progression from adenoma to carcinoma (late-stage progression). * **PTEN:** A tumor suppressor gene on chromosome 10. Mutations are classically associated with **Cowden Syndrome** and endometrial/prostate cancers, rather than being the primary gatekeeper for colon cancer. * **STK11 (LKB1):** Mutations in this gene are associated with **Peutz-Jeghers Syndrome**, characterized by hamartomatous polyps and increased risk of various visceral cancers. **High-Yield Clinical Pearls for NEET-PG:** * **FAP (Familial Adenomatous Polyposis):** Caused by a germline mutation in APC; 100% risk of colon cancer if not treated. * **Turcot Syndrome:** FAP/APC mutation + Medulloblastoma. * **Gardner Syndrome:** FAP + Osteomas (mandible) + Desmoid tumors + Epidermoid cysts. * **Sequence of mutations:** APC (early) → KRAS (intermediate) → TP53/SMADs (late) [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 304-305. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 819.
Question 737: What is the most common type of cell death resulting from sudden occlusion of blood supply?
- A. Coagulation necrosis (Correct Answer)
- B. Caseation necrosis
- C. Liquefactive necrosis
- D. Gangrene
Explanation: **Explanation:** **1. Why Coagulation Necrosis is Correct:** Coagulation necrosis is the most common pattern of cell death following **ischemia (hypoxia)** caused by the sudden occlusion of blood supply to any organ (except the brain). The underlying mechanism involves the **denaturation of structural proteins and enzymes**. Because the lysosomal enzymes are also denatured, they cannot digest the cell. This results in the characteristic histological finding where the **basic outline of the cell is preserved** for several days, but the nucleus is lost (tombstone appearance). **2. Why the Other Options are Incorrect:** * **Caseation Necrosis:** This is a specific form of necrosis seen typically in **Tuberculosis**. It is characterized by a "cheese-like" friable white appearance and is a combination of coagulation and liquefactive necrosis. * **Liquefactive Necrosis:** This occurs when enzymatic digestion of dead cells prevails. It is the characteristic response to **ischemia in the CNS (Brain)** [1] and is also seen in focal bacterial or fungal infections (abscess formation). * **Gangrene:** This is not a distinct pattern of cell death but rather a clinical term [1]. It usually refers to coagulation necrosis (Dry Gangrene) of a limb that has lost its blood supply, or when complicated by bacterial infection (Wet Gangrene) [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Exception Rule:** Ischemia leads to coagulation necrosis in all solid organs **EXCEPT the brain**, where it leads to liquefactive necrosis [1]. * **Morphology:** On H&E stain, coagulative necrotic cells show increased eosinophilia (pinker appearance) due to loss of cytoplasmic RNA and increased binding of eosin to denatured proteins. * **Infarction:** A localized area of coagulation necrosis is called an **infarct** [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 148-149. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 140-142. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 103-104.
Question 738: Which of the following findings is characteristic of Marfan's syndrome?
- A. Mutation of the fibrillin-1 gene
- B. Flat cornea
- C. Aortic aneurysm
- D. All of the above (Correct Answer)
Explanation: **Explanation:** Marfan’s syndrome is an **autosomal dominant** disorder of connective tissue caused by a defect in the **FBN1 gene** located on chromosome **15q21**. This gene encodes **fibrillin-1**, a glycoprotein essential for the structural integrity of the extracellular matrix and the regulation of Transforming Growth Factor-beta (TGF-β) signaling [2]. * **Mutation of the fibrillin-1 gene (Option A):** This is the primary molecular defect. Fibrillin-1 is a major component of microfibrils, which serve as a scaffold for elastin. Deficiency leads to weakened connective tissue and excessive TGF-β activation [2]. * **Flat cornea (Option B):** While ectopia lentis (dislocation of the lens, typically upward and outward) is the most classic ocular finding, a **flat cornea** (decreased corneal curvature) is a recognized diagnostic criterion in the Ghent nosology. * **Aortic aneurysm (Option C):** Cardiovascular complications are the most life-threatening. Fragmentation of elastic fibers in the tunica media leads to **cystic medial necrosis**, resulting in aortic root dilation, aneurysms, and potentially fatal aortic dissection [1, 3]. **Clinical Pearls for NEET-PG:** * **Skeletal features:** Arachnodactyly (long fingers), pectus excavatum/carinatum, and a high-arched palate [2]. * **Steinberg sign (Thumb sign)** and **Walker-Murdoch sign (Wrist sign)** are used to assess joint laxity/long digits. * **Cardiovascular:** Mitral Valve Prolapse (MVP) is common; Aortic dissection is the leading cause of death [1, 3]. * **Differential:** Marfan’s is often confused with **Homocystinuria**. Key difference: Marfan’s has upward lens dislocation and normal intellect, while Homocystinuria has downward lens dislocation, intellectual disability, and increased risk of thrombosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 511-512. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 153-154. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Cardiovascular Disease, pp. 272-273.
Question 739: Which CD marker represents the leucocyte common antigen?
- A. CD 14
- B. CD 15
- C. CD 23
- D. CD 45 (Correct Answer)
Explanation: ### Explanation **Correct Option: D (CD 45)** CD 45 is known as the **Leucocyte Common Antigen (LCA)**. It is a transmembrane protein tyrosine phosphatase expressed on the surface of **all hematopoietic cells**, except for mature erythrocytes and platelets. In diagnostic pathology, CD 45 is the primary immunohistochemical (IHC) marker used to differentiate **lymphomas/leukemias** from non-hematopoietic tumors like carcinomas or sarcomas. **Analysis of Incorrect Options:** * **A. CD 14:** This is a specific marker for **monocytes and macrophages**. It acts as a co-receptor for bacterial lipopolysaccharide (LPS). * **B. CD 15:** This marker is expressed on **Reed-Sternberg cells** (in classical Hodgkin Lymphoma, along with CD 30) and is also found on mature **granulocytes**. * **C. CD 23:** This is a low-affinity IgE receptor [1]. It is a key marker for **B-cell Chronic Lymphocytic Leukemia (CLL)** and is used to differentiate it from Mantle Cell Lymphoma (which is CD 23 negative) [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Pan-B cell markers:** CD 19, CD 20 [1]. * **Pan-T cell markers:** CD 3 (most specific), CD 2, CD 5, CD 7 [1]. * **NK cell markers:** CD 16, CD 56. * **Hairy Cell Leukemia:** Characterized by CD 11c, CD 25, and CD 103 [1]. * **Stem cell marker:** CD 34 (used to identify blasts in acute leukemia). * **Memory Tip:** If a tumor is "LCA positive," think Lymphoma; if "Cytokeratin positive," think Carcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 598.
Question 740: Who discovered the process of phagocytosis?
- A. Virchow
- B. Metchnikoff (Correct Answer)
- C. Koch
- D. None of the above
Explanation: **Explanation:** **1. Why Metchnikoff is Correct:** **Elie Metchnikoff**, a Russian zoologist, is known as the **"Father of Natural Immunity."** In 1882, while studying starfish larvae, he observed specialized cells engulfing foreign carmine particles. He termed this process **phagocytosis** (from the Greek *phagein*, meaning "to eat"). His discovery shifted the understanding of immunity from purely chemical (humoral) to cellular, earning him the Nobel Prize in 1908. Phagocytosis is a critical component of the innate immune response [3], involving the ingestion and digestion of microbes or cellular debris by neutrophils and macrophages [1]. **2. Why Other Options are Incorrect:** * **Virchow (Rudolf Virchow):** Known as the **"Father of Modern Pathology."** He is famous for the concept of *Omnis cellula e cellula* (all cells come from cells) and for describing the "Virchow’s Triad" in thrombosis. He focused on cellular pathology but did not discover phagocytosis. * **Koch (Robert Koch):** Known as the **"Father of Medical Microbiology."** He formulated **Koch’s Postulates** and identified the causative agents of Anthrax, Tuberculosis, and Cholera. His work was primarily focused on the germ theory of disease rather than the host's cellular immune response. **3. NEET-PG Clinical Pearls & High-Yield Facts:** * **Steps of Phagocytosis:** Recognition and Attachment (via opsonins like C3b and IgG) → Engulfment → Killing/Degradation (via ROS and lysosomal enzymes) [1]. * **Opsonization:** The process of "coating" a particle to enhance phagocytosis [2]. The most important opsonins are **C3b** and **IgG (Fc fragment)** [1]. * **Defects in Phagocytosis:** * **Chédiak-Higashi Syndrome:** Defect in phagolysosome fusion. * **Chronic Granulomatous Disease (CGD):** Defect in NADPH oxidase, leading to an inability to produce a respiratory burst. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 83-84, 89-91. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 190-191. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 194-196.
Practice by Chapter
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free